Establishes "New Jersey Right to Try-Plus Act" permitting terminally ill patients access to certain investigational and off-label treatments.
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Overview
The New Jersey Right to Try-Plus Act would allow terminally ill patients access to certain investigational and off-label treatments. It expands upon existing ‘Right to Try’ laws by permitting access to drugs, biological products, and devices that have completed phase one clinical trials but haven’t received full FDA approval. Patients must meet specific criteria, including a life expectancy of 12 months or less, and receive a prescription from a licensed physician. The bill also requires hospitals to provide off-label treatments to patients who meet certain requirements.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours